Known targets — ChEMBL curated mechanism
CHRM1CHRM2CHRM3CHRM4CHRM5SLC6A2dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.62 |
| ▸ | CA1 | P00915 | 3/20 | 0.56 |
| ▸ | CA2 | P00918 | 3/20 | 0.56 |
| ▸ | CA12 | O43570 | 1/20 | 0.56 |
| ▸ | CA3 | P07451 | 1/20 | 0.56 |
| ▸ | CA6 | P23280 | 1/20 | 0.56 |
| ▸ | CA5A | P35218 | 1/20 | 0.56 |
| ▸ | CA7 | P43166 | 1/20 | 0.56 |
| ▸ | CA9 | Q16790 | 1/20 | 0.56 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.56 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.50 |
| ▸ | MMP1 | P03956 | 1/20 | 0.50 |
| ▸ | MMP2 | P08253 | 1/20 | 0.50 |
| ▸ | MMP9 | P14780 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15766180 | 0.94 | GAA (0.62) | GAACA1CA2CA12CA3 | |
| SCHEMBL16034285 | 0.94 | GAA (0.62) | GAACA1CA2CA12CA3 | |
| SCHEMBL8943269 | 0.94 | GAA (0.62) | GAACA1CA2CA12CA3 | |
| SCHEMBL18274782 | 0.94 | GAA (0.62) | GAACA1CA2CA12CA3 | |
| SCHEMBL17982097 | 0.94 | GAA (0.62) | GAACA1CA2CA12CA3 | |
| SCHEMBL8622705 | 0.94 | GAA (0.62) | GAACA1CA2CA12CA3 | |
| SCHEMBL6917577 | 0.94 | GAA (0.62) | GAACA1CA2CA12CA3 | |
| SCHEMBL22615914 | 0.94 | GAA (0.62) | GAACA1CA2CA12CA3 | |
| SCHEMBL20583857 | 0.94 | GAA (0.62) | GAACA1CA2CA12CA3 | |
| SCHEMBL10917087 | 0.94 | GAA (0.62) | GAACA1CA2CA12CA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4678725-A1 | CO-GRANULES COMPRISING BLEACHING CATALYST, BLEACHING ACTIVATOR, BINDER AND ZINC OR BISMUTH SALT, AND BLEACHING AND CLEANING AGENT COMPRISING SAME | Catexel GmbH (DE) | 2026-01-14 | — | — | EP | disclosed |
| CN-115362193-A | Epoxy resin and electrodeposition paint | 关西涂料株式会社 | 2022-11-18 | — | — | CN | disclosed |
| EP-2818525-B1 | ELECTRODEPOSITION COATING COMPOSITION, AND CATALYST FOR ELECTRODEPOSITION COATING COMPOSITION | NITTO KASEI CO LTD (JP) | 2016-12-28 | — | — | EP | disclosed |
| US-20150008125-A1 | ELECTRODEPOSITION COATING COMPOSITION, AND CATALYST FOR ELECTRODEPOSITION COATING COMPOSITION | NITTO KASEI CO., LTD. (JP) | 2015-01-08 | — | — | US | disclosed |
| EP-2818525-A1 | ELECTRODEPOSITION COATING COMPOSITION, AND CATALYST FOR ELECTRODEPOSITION COATING COMPOSITION | Nitto Kasei Co., Ltd. (JP) | 2014-12-31 | — | — | EP | disclosed |
| US-8716426-B2 | Method for preparing an allophanate, allophanate, and low-viscosity composition containing the allophanate | PERSTORP FRANCE (FR) | 2014-05-06 | — | — | US | disclosed |
| US-20120016073-A1 | METHOD FOR PREPARING AN ALLOPHANATE, ALLOPHANATE, AND LOW-VISCOSITY COMPOSITION CONTAINING THE ALLOPHANATE | PERSTORP FRANCE (FR) | 2012-01-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120016073-A1 | METHOD FOR PREPARING AN ALLOPHANATE, ALLOPHANATE, AND LOW-VISCOSITY COMPOSITION CONTAINING THE ALLOPHANATE | FHIT, DOHH, MTDH | GAA 1435/4885CA1 177/4885CA2 671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.